Atherosclerotic and Thrombogenic Neointima Formed Over Sirolimus Drug-Eluting Stent An Angioscopic Study

被引:127
作者
Higo, Tomoaki [1 ]
Ueda, Yasunori [1 ]
Oyabu, Jota [1 ]
Okada, Katsuki [1 ]
Nishio, Mayu [1 ]
Hirata, Akio [1 ]
Kashiwase, Kazunori [1 ]
Ogasawara, Nobuyuki [1 ]
Hirotani, Shinichi [1 ]
Kodama, Kazuhisa [1 ]
机构
[1] Osaka Police Hosp, Div Cardiovasc, Tennoji Ku, Osaka 5430035, Japan
关键词
drug-eluting stent; neointima; yellow neointima; thrombus; HUMAN CORONARY-ARTERIES; LATE THROMBOSIS; SLOW-RELEASE; DOUBLE-BLIND; COVERAGE; LESIONS; TRIAL;
D O I
10.1016/j.jcmg.2008.12.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to examine by angioscopy the neointima formation and thrombogenic potential of the neointima after deployment of a drug-eluting stent (DES). BACKGROUND Late stent thrombosis after DES implantation, a major safety concern, has been associated with poor strut coverage by neointima. Intracoronary angioscopy provides a method for visual evaluation of stent coverage by neointima and detection of thrombus in the stented coronary segment. METHODS Patients undergoing implantation of a sirolimus DES (n = 57) were serially examined by angioscopy immediately after (baseline) and again at 10 months (follow-up) after implantation. The angioscopic color grade of the neointima from white to yellow was assessed in a semiquantitative manner. Stent coverage was classified into not covered (Grade 0), covered by a thin layer (Grade 1), or buried under neointima (Grade 2). The thrombogenic potential of the neointima was evaluated by the prevalence of thrombus on the neointima. RESULTS The maximum yellow color grade of the neointima within DES-implanted lesions increased significantly from baseline to follow-up (1.4 +/- 1.1 vs. 1.9 +/- 0.6, p = 0.0008). Even among lesions without yellow color at baseline, yellow color was detected in 94% (17 of 18) of lesions at follow-up. The prevalence of thrombus was significantly higher on the yellow than on the white neointimal areas. Thrombus was detected on yellow and/or Grade-0/1 neointima, but never on the white Grade-2 neointima. CONCLUSIONS Sirolimus DES promoted formation of atherosclerotic yellow neointima in the stent-implanted lesion at 10-month follow-up. Thrombus was detected more often on the yellow area than on the white area and was never detected where a stent was buried under white neointima. These data suggest that the increased potential risk of late stent thrombosis in DES lesions may be due to the newly formed yellow neotima and cholesterol-laden plaque. (J Am Coll Cardiol Img 2009; 2: 616-24) (C) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:616 / 624
页数:9
相关论文
共 30 条
[1]   Remodeling of in-stent neointima, which became thinner and transparent over 3 years - Serial angiographic and angioscopic follow-up [J].
Asakura, M ;
Ueda, Y ;
Nanto, S ;
Hirayama, A ;
Adachi, T ;
Kitakaze, M ;
Hori, M ;
Kodama, K .
CIRCULATION, 1998, 97 (20) :2003-2006
[2]   Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation [J].
Awata, Masaki ;
Kotani, Jun-ichi ;
Uematsu, Masaaki ;
Morozumi, Takakazu ;
Watanabe, Tetsuya ;
Onishi, Toshinari ;
Iida, Osamu ;
Sera, Fusako ;
Nanto, Shinsuke ;
Hori, Masatsugu ;
Nagata, Seiki .
CIRCULATION, 2007, 116 (08) :910-916
[3]   Mechanisms of neointima formation and remodeling in the porcine coronary artery [J].
Christen, T ;
Verin, V ;
Bochaton-Piallat, ML ;
Popowski, Y ;
Ramaekers, F ;
Debruyne, P ;
Camenzind, E ;
van Eys, G ;
Gabbiani, G .
CIRCULATION, 2001, 103 (06) :882-888
[4]   Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions [J].
Colombo, A ;
Drzewiecki, J ;
Banning, A ;
Grube, E ;
Hauptmann, K ;
Silber, S ;
Dudek, D ;
Fort, S ;
Schiele, F ;
Zmudka, K ;
Guagliumi, G ;
Russell, ME .
CIRCULATION, 2003, 108 (07) :788-794
[5]   Pathology of acute and chronic coronary stenting in humans [J].
Farb, A ;
Sangiorgi, G ;
Carter, AJ ;
Walley, VM ;
Edwards, WD ;
Schwartz, RS ;
Virmani, R .
CIRCULATION, 1999, 99 (01) :44-52
[6]   Very late thrombosis after drug-eluting stents [J].
Feres, Fausto ;
Costa, J. Ribamar, Jr. ;
Abizaid, Alexandre .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 68 (01) :83-88
[7]   Vascular responses to drug eluting stents - Importance of delayed healing [J].
Finn, Aloke V. ;
Nakazawa, Gaku ;
Joner, Michael ;
Kolodgie, Frank D. ;
Mont, Erik K. ;
Gold, Herman K. ;
Virmani, Renu .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (07) :1500-1510
[8]   Pathological correlates of late drug-eluting stent thrombosis - Strut coverage as a marker of endothelialization [J].
Finn, Aloke V. ;
Joner, Michael ;
Nakazawa, Gaku ;
Kolodgie, Frank ;
Newell, John ;
John, Mike C. ;
Gold, Herman K. ;
Virmani, Renu .
CIRCULATION, 2007, 115 (18) :2435-2441
[9]   Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent - The European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial [J].
Gershlick, A ;
De Scheerder, I ;
Chevalier, B ;
Stephens-Lloyd, A ;
Camenzind, E ;
Vrints, C ;
Reifart, N ;
Missault, L ;
Goy, JJ ;
Brinker, JA ;
Raizner, AE ;
Urban, P ;
Heldman, AW .
CIRCULATION, 2004, 109 (04) :487-493
[10]   Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions [J].
Grube, E ;
Silber, S ;
Hauptmann, KE ;
Mueller, R ;
Buellesfeld, L ;
Gerckens, U ;
Russell, ME .
CIRCULATION, 2003, 107 (01) :38-42